A detailed history of Hrt Financial LP transactions in Celcuity Inc. stock. As of the latest transaction made, Hrt Financial LP holds 9,311 shares of CELC stock, worth $860,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,311
Previous 26,386 64.71%
Holding current value
$860,708
Previous $352,000 29.83%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$12.58 - $62.68 $214,803 - $1.07 Million
-17,075 Reduced 64.71%
9,311 $457,000
Q2 2025

Aug 14, 2025

BUY
$8.21 - $13.35 $216,629 - $352,253
26,386 New
26,386 $352,000
Q4 2021

Feb 14, 2022

SELL
$11.96 - $19.35 $124,085 - $200,756
-10,375 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$17.35 - $24.87 $180,006 - $258,026
10,375 New
10,375 $186,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $1.38B
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.